Glaucoma affects peripheral vision, creating blind spots in the outer edges of a person’s visual field. This can affect daily activities such as driving and walking. Glaucoma is the name for a group ...

There are typically no visual changes in the initial stages of glaucoma. As damage occurs to the optic nerve, people may develop blind spots in their peripheral visual field. Some can see halos and ...

Glaucoma is the term for a group of eye conditions that damage the optic nerve at the back of the eye. Without treatment, it can lead to vision loss and blindness. Glaucoma is not a life threatening ...

Learn about causes of gradual and sudden-onset blurred vision, from eyestrain and refractive errors to cataracts and strokes, ...

Larissa Camejo, MD: I’m a glaucoma specialist and the owner of a solo private practice in Palm Beach Gardens, Florida. Our ...

Glaucoma is a group of eye conditions that can lead to vision loss. Health experts are unsure of the exact cause of glaucoma. When a person has glaucoma, fluid does not properly drain out of the eye.

Université de Montréal provides funding as a founding partner of The Conversation CA-FR. Université de Montréal provides funding as a member of The Conversation CA. Like high blood pressure, glaucoma ...

Please provide your email address to receive an email when new articles are posted on . Glaucoma patients deserve the best level of care, and this includes any new technologies that allow them to ...

Cases of this eye condition are expected to increase around the world to 22 million by the year 2040. The key to holding onto your vision is getting diagnosis and treatment early.

To examine changes in rates of visual field (VF) progression in patients attending a sample of glaucoma clinics in England between 1999 and 2012. An archive of 473 252 Humphrey VFs recorded across the ...

Annual event accelerates progress toward curing glaucoma, from groundbreaking research to emerging therapies SAN FRANCISCO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Glaucoma Research Foundation (GRF) today ...

Most patients do well on topical therapy, but innovation in IOP-lowering drops remains essential. One might ask why topical eye drop medications remain the mainstay of glaucoma therapy in the US and ...